Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, May 1996, 287-289, Vol 3, No. 3
I Nachamkin, DL Riddle, M Feldman and PH Edelstein
We performed a retrospective study on patients who had a positive screening
antibody test result for antibody to Borrelia burgdorferi to determine the
clinical indicators used by physicians to order this test. Eighty-two
evaluable patients who were screen positive (indirect enzyme-linked
immunosorbent assay) between August 1991 and March 1993 were included.
Additional tests, isotype-specific capture immunoglobulin enzyme
immunoassay and Western blot (immunoblot) analysis (immunoglobulin G), were
performed on positive samples. Of 82 patients with a positive screening
test result, 54 (66%) had no serologic evidence of Lyme disease on the
basis of additional testing (positive predictive value, 34%). Only 28 of 82
patients (34%) had clinical indicators suggestive of Lyme disease. Antibody
screening tests may provide misleading information if they are not
accompanied by more specific assays. Inappropriate testing of patients
without indications of Lyme disease is frequently performed, and the
ordering practices of physicians should be reassessed.
Copyright © 1996 by the American Society for Microbiology. All rights reserved.
Utilization of tests for Lyme disease antibody at a university hospital
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104-4283, USA. Nachamki@mail.med.upenn.edu
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |